CHLA-32 (Q54812497)

From Wikidata

Jump to navigation Jump to search

cell line

CHLA32

Language	Label	Description	Also known as
English	CHLA-32	cell line	CHLA32

Statements

1 reference

Cellosaurus release 44

7 January 2023

cancer cell line

1 reference

Cellosaurus release 44

7 January 2023

described by source

Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators

1 reference

Cellosaurus release 44

7 January 2023

Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines

1 reference

Cellosaurus release 44

7 January 2023

The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation

1 reference

Cellosaurus release 44

7 January 2023

Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression

1 reference

Cellosaurus release 44

7 January 2023

established from medical condition

medulloblastoma

1 reference

Cellosaurus release 36

20 November 2020

derived from organism type

1 reference

Cellosaurus release 44

7 January 2023

Identifiers

1 reference

Cellosaurus release 44

7 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54812497&oldid=1861200357"